Bavarian Nordic A/S (BVNRY)
OTCMKTS: BVNRY · Delayed Price · USD
7.45
+0.24 (3.33%)
May 3, 2024, 3:59 PM EDT - Market closed

Bavarian Nordic Revenue

In the year 2023, Bavarian Nordic had annual revenue of 7.06B DKK with 123.99% growth. Revenue in the quarter ending December 31, 2023 was 2.45B DKK with 89.81% year-over-year growth.

Revenue (ttm)
7.06B DKK
Revenue Growth
+124.21%
P/S Ratio
1.71
Revenue / Employee
5,122,941 DKK
Employees
1,379
Market Cap
1.74B USD

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.06B3.91B123.99%
Dec 31, 20223.15B1.25B66.02%
Dec 31, 20211.90B45.49M2.46%
Dec 31, 20201.85B1.19B179.61%
Dec 31, 2019662.49M161.87M32.33%
Dec 31, 2018500.62M-869.53M-63.46%
Dec 31, 20171.37B363.41M36.10%
Dec 31, 20161.01B-13.82M-1.35%
Dec 31, 20151.02B-196.25M-16.13%
Dec 31, 20141.22B4.31M0.36%
Dec 31, 20131.21B195.87M19.27%
Dec 31, 20121.02B493.04M94.16%
Dec 31, 2011523.60M209.53M66.71%
Dec 31, 2010314.07M239.29M319.98%
Dec 31, 200974.78M-134.02M-64.19%
Dec 31, 2008208.81M-123.30M-37.13%
Dec 31, 2007332.10M156.81M89.46%
Dec 31, 2006175.29M-72.30M-29.20%
Dec 31, 2005247.60M82.81M50.26%
Dec 31, 2004164.78M-339.86M-67.35%
Dec 31, 2003504.64M383.57M316.79%
Dec 31, 2002121.08M--
Dec 31, 20010--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 371.62B
Johnson & Johnson 81.80B
Merck & Co. 60.12B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings